JP5565926B2 - 眼科手術方法およびこれに用いるキット - Google Patents

眼科手術方法およびこれに用いるキット Download PDF

Info

Publication number
JP5565926B2
JP5565926B2 JP2009020218A JP2009020218A JP5565926B2 JP 5565926 B2 JP5565926 B2 JP 5565926B2 JP 2009020218 A JP2009020218 A JP 2009020218A JP 2009020218 A JP2009020218 A JP 2009020218A JP 5565926 B2 JP5565926 B2 JP 5565926B2
Authority
JP
Japan
Prior art keywords
viscoelastic substance
viscoelastic
substance
anterior chamber
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009020218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009178558A (ja
JP2009178558A5 (enExample
Inventor
孝男 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Seikagaku Corp
Original Assignee
Santen Pharmaceutical Co Ltd
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Seikagaku Corp filed Critical Santen Pharmaceutical Co Ltd
Publication of JP2009178558A publication Critical patent/JP2009178558A/ja
Publication of JP2009178558A5 publication Critical patent/JP2009178558A5/ja
Application granted granted Critical
Publication of JP5565926B2 publication Critical patent/JP5565926B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
JP2009020218A 2008-01-30 2009-01-30 眼科手術方法およびこれに用いるキット Active JP5565926B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2458908P 2008-01-30 2008-01-30
US61/024,589 2008-01-30

Publications (3)

Publication Number Publication Date
JP2009178558A JP2009178558A (ja) 2009-08-13
JP2009178558A5 JP2009178558A5 (enExample) 2012-02-09
JP5565926B2 true JP5565926B2 (ja) 2014-08-06

Family

ID=40932397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009020218A Active JP5565926B2 (ja) 2008-01-30 2009-01-30 眼科手術方法およびこれに用いるキット

Country Status (2)

Country Link
US (1) US9539138B2 (enExample)
JP (1) JP5565926B2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638239B1 (en) 2000-04-14 2003-10-28 Glaukos Corporation Apparatus and method for treating glaucoma
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
CA2442652C (en) 2001-04-07 2011-01-04 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
AU2007319383A1 (en) 2006-11-10 2008-05-22 Glaukos Corporation Uveoscleral shunt and methods for implanting same
US9089592B2 (en) * 2007-04-26 2015-07-28 Seikagaku Corporation Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material, a composition for evaluation of a viscoelastic material and a method for evaluation using the composition
WO2012071476A2 (en) 2010-11-24 2012-05-31 David Haffner Drug eluting ocular implant
WO2013148275A2 (en) 2012-03-26 2013-10-03 Glaukos Corporation System and method for delivering multiple ocular implants
CA2878510C (en) 2012-07-27 2021-06-08 The Regents Of The University Of California Microinjection catheter
US9592151B2 (en) 2013-03-15 2017-03-14 Glaukos Corporation Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
US11116625B2 (en) 2017-09-28 2021-09-14 Glaukos Corporation Apparatus and method for controlling placement of intraocular implants
CN113893085B (zh) 2017-10-06 2024-05-24 格劳科斯公司 用于递送多个眼部植入物的系统和方法
USD846738S1 (en) 2017-10-27 2019-04-23 Glaukos Corporation Implant delivery apparatus
JP7095996B2 (ja) * 2018-01-15 2022-07-05 参天製薬株式会社 眼科手術用組成物及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
ES2199940T3 (es) * 1992-02-10 2004-03-01 Advanced Medical Optics, Inc. Formulaciones de hialuronato de peso molecular bimodal y metodos de utilizacion.
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
DK172900B1 (da) * 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
US20020183279A1 (en) 2001-04-18 2002-12-05 Koichiro Tanaka Pharmaceutical composition containing viscoelastic substance and medication
US7363928B2 (en) 2001-12-21 2008-04-29 Alcon, Inc. Dilution resistant viscoelastic compositions
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US6844024B2 (en) * 2003-06-13 2005-01-18 Ast Products, Inc. Methods for coating implants
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
CA2580890C (en) * 2004-09-21 2013-10-22 Thom Terwee Viscoelastic solution or gel formulation, and methods of treating a body site with the same

Also Published As

Publication number Publication date
US20090198213A1 (en) 2009-08-06
JP2009178558A (ja) 2009-08-13
US9539138B2 (en) 2017-01-10

Similar Documents

Publication Publication Date Title
JP5565926B2 (ja) 眼科手術方法およびこれに用いるキット
Borkenstein et al. Ophthalmic viscosurgical devices (OVDs) in challenging cases: a review
US5792103A (en) Viscosurgical method and apparatus
Miyata et al. Corneal endothelial cell protection during phacoemulsification: low-versus high-molecular-weight sodium hyaluronate
EA002004B1 (ru) Композиция для офтальмологических хирургических операций (варианты) и способ их осуществления
JPH07116030B2 (ja) 残留水晶体物質除去補助剤
US20040167480A1 (en) Administration of multiple viscoelastic solutions with a multi-compartment syringe
Altıntaş et al. Toxic anterior segment syndrome outbreak after cataract surgery triggered by viscoelastic substance
Elvira et al. Induced endothelial cell loss in phacoemulsification using topical anesthesia plus intracameral lidocaine
JP2008520392A (ja) 天然ポリマーの粘弾性組成物
US20070137657A1 (en) Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases
US20050215515A1 (en) Viscoelastic composition, method of use and package
Auffarth et al. Comparison of the performance and safety of 2 ophthalmic viscosurgical devices in cataract surgery
Tognetto et al. Survey of ophthalmic viscosurgical devices
US7363928B2 (en) Dilution resistant viscoelastic compositions
BRPI0215189B1 (pt) composição viscoelástica aquosa, estéril, para uso em procedimentos cirúrgicos oftálmicos
Huang et al. Toxic anterior segment syndrome after pediatric cataract surgery
Wilkie et al. Agents for intraocular surgery
Kim et al. Effects of senofilcon A mechanical protector on corneal endothelial cells during phacoemulsification in rabbit eyes: pilot study
US20060003964A1 (en) Dilution resistant viscoelastic compositions
CN1921833A (zh) 藻酸盐粘弹性组合物、使用方法及包装
Perone et al. Safety and efficacy of two ocular anesthetic methods for phacoemulsification: Topical anesthesia and viscoanesthesia (VisThesia™)
Koopmans et al. Prevention of capsular opacification after accommodative lens refilling surgery in rabbits
Ben-Eliahu et al. Protective effect of different ophthalmic viscosurgical devices on corneal endothelial cells during phacoemulsification: rabbit model
RU2626693C1 (ru) Способ лечения подвывихнутого хрусталика у пациентов молодого возраста

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130409

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130411

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131226

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20140218

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140520

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140616

R150 Certificate of patent or registration of utility model

Ref document number: 5565926

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250